FDA Clearance Tracker · P200037-S004
Assure Wearable Cardioverter Defibrillator (WCD) system
Last checked: Nov 20, 2026Latest source record: Oct 25, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Oct 25, 2022
Approved
Time to decision
145 days
Received Jun 2, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P200037-S004
- Device name
- Assure Wearable Cardioverter Defibrillator (WCD) system
- Applicant
- Kestra Medical Technologies, Inc.
- Applicant location
- Kirkland, WA
- Received
- Jun 2, 2022
- Decided
- Oct 25, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P200037
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for a revision to the software system to version 5.0 with a feature to provide additional information to the physician about the patients health.
Source documents
Other decisions for Kestra Medical Technologies, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- ASSURE Wearable ECG510(k)
K233864 · Decided May 7, 2024 · 153 days after receipt
Device type: Electrocardiograph, Ambulatory (Without Analysis) (MWJ) · Cardiology
P200037 · Decided Jul 27, 2021 · 348 days after receipt
Device type: Wearable automated external defibrillator (MVK) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.